CTOs on the Move

RADi Medical Systems

www.radi.se

 
RADi Medical Systems is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.radi.se
  • 200 Research Dr
    Wilmington, MA USA 01887
  • Phone: 877.337.7234

Executives

Name Title Contact Details

Similar Companies

Sterilmed

The merged expertise of SterilMed and The Scope Exchange in the repair and reprocessing of medical devices provides the opportunity to utilize a comprehensive single-source supplier. The merged expertise combined with SterilMed's broad market presence

Medstar Surgical

Medstar Surgical is a College Point, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.

BioSphere Medical, Inc.

BioSphere Medical, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.